Low dose rate brachytherapy using a tandem for cervical cancer

Area of Science:

• Gynecology
• Oncology
• Radiation Oncology

Background:

• Cervical cancer treatment often involves radiation therapy, including brachytherapy.
• Anatomical distortions or prior treatments can complicate standard brachytherapy techniques.
• The use of a tandem alone, without ovoids, is an alternative approach in specific clinical scenarios.

Purpose of the Study:

• To evaluate the efficacy of low dose rate brachytherapy using only a tandem for cervical cancer.
• To compare outcomes of tandem-only brachytherapy with historical data or standard tandem-and-ovoid techniques.
• To assess local control and survival rates in patients treated with tandem-only brachytherapy.

Main Methods:

• A retrospective analysis of 120 cervical cancer patients treated with low dose rate brachytherapy using only a tandem.
• Patients received a total external beam radiation dose of 50-50.4 Gy and a brachytherapy dose of 30 Gy to point A.
• Follow-up data on local control, recurrence, and survival were collected and analyzed.

Main Results:

• A complete clinical response rate of 83% was observed at the end of brachytherapy.
• Recurrence rates varied by stage, with notable frequencies in IB1 (20%), IIB (40%), and IIIB (25%).
• Overall survival rates were encouraging, with median survival ranging from 24 to 30 months across different FIGO stages.

Conclusions:

• Low dose rate brachytherapy with a tandem alone is a viable treatment option for cervical cancer, particularly in cases with anatomical challenges.
• Preliminary findings suggest no significant difference in outcomes compared to traditional tandem-and-ovoid brachytherapy.
• This technique offers an effective alternative for achieving local control and survival in select cervical cancer patients.